BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2084323)

  • 1. Normal restriction pattern (Hind III) of the myoadenylate deaminase gene in enzyme deficient patients.
    Gross M; Morisaki T; Pongratz D; Holmes EW; Zöllner N
    Klin Wochenschr; 1990 Nov; 68(21):1084. PubMed ID: 2084323
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency.
    Gross M
    J Inherit Metab Dis; 1997 Jun; 20(2):186-92. PubMed ID: 9211191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
    Gross M; Rötzer E; Kölle P; Mortier W; Reichmann H; Goebel HH; Lochmüller H; Pongratz D; Mahnke-Zizelman DK; Sabina RL
    Neuromuscul Disord; 2002 Aug; 12(6):558-65. PubMed ID: 12117480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoadenylate deaminase deficiency.
    Shumate JB; Katnik R; Ruiz M; Kaiser K; Frieden C; Brooke MH; Carroll JE
    Muscle Nerve; 1979; 2(3):213-6. PubMed ID: 503106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance and neuropathology of primary MADD in C34-T and G468-T mutations of the AMPD1 gene.
    Fischer S; Drenckhahn C; Wolf C; Eschrich K; Kellermann S; Froster UG; Schober R
    Clin Neuropathol; 2005; 24(2):77-85. PubMed ID: 15803807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ergometer exercise in myoadenylate deaminase deficient patients.
    Gross M; Gresser U
    Clin Investig; 1993 Jun; 71(6):461-5. PubMed ID: 8353405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoadenylate deaminase deficiency: a new disease of muscle.
    Fishbein WN; Armbrustmacher VW; Griffin JL
    Science; 1978 May; 200(4341):545-8. PubMed ID: 644316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of a treatment with xylitol in a patient with myoadenylate deaminase deficiency.
    Bruyland M; Ebinger G
    Clin Neuropharmacol; 1994 Oct; 17(5):492-3. PubMed ID: 9316703
    [No Abstract]   [Full Text] [Related]  

  • 9. Myalgia with partial defects of mitochondrial enzyme and myoadenylate deaminase.
    Tsao CY; McComb RD
    Pediatr Neurol; 1990; 6(1):65. PubMed ID: 2155618
    [No Abstract]   [Full Text] [Related]  

  • 10. Myoadenylate deaminase deficiency myopathy in pregnancy.
    Bellver J; Cervera J; Boldó A; Abad A; Perales A; Garcia Domenech R; Román JA; Monleón J
    Arch Gynecol Obstet; 1997; 259(3):157-9. PubMed ID: 9187470
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myoadenylate deaminase deficiency].
    Higuchi I
    Ryoikibetsu Shokogun Shirizu; 2001; (36):122-5. PubMed ID: 11596341
    [No Abstract]   [Full Text] [Related]  

  • 12. The genetic basis of myoadenylate deaminase deficiency is heterogeneous.
    Rötzer E; Mortier W; Reichmann H; Gross M
    Adv Exp Med Biol; 1998; 431():129-33. PubMed ID: 9598045
    [No Abstract]   [Full Text] [Related]  

  • 13. Myoadenylate deaminase deficiency: clinico-pathological and molecular study of a series of 27 Spanish cases.
    Teijeira S; San Millán B; Fernández JM; Rivas E; Viéitez I; Miranda S; González F; Navarro C
    Clin Neuropathol; 2009; 28(2):136-42. PubMed ID: 19353846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myoadenylate deaminase deficiency].
    Takeda M; Wada Y
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):451-3. PubMed ID: 9590098
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of D-ribose in myoadenylate deaminase deficiency.
    Lecky BR
    Lancet; 1983 Jan; 1(8317):193. PubMed ID: 6130241
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of genetically proven deficiencies of myophosphorylase and AMP deaminase: a second case of 'double trouble'.
    Rubio JC; Martín MA; Bautista J; Campos Y; Segura D; Arenas J
    Neuromuscul Disord; 1997 Sep; 7(6-7):387-9. PubMed ID: 9327403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant carnitine palmitoyltransferase associated with myoadenylate deaminase deficiency in skeletal muscle.
    Reuschenbach C; Zierz S
    J Pediatr; 1988 Apr; 112(4):600-3. PubMed ID: 3351687
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial myoadenylate deaminase deficiency and exertional myalgia.
    Kelemen J; Rice DR; Bradley WG; Munsat TL; DiMauro S; Hogan EL
    Neurology; 1982 Aug; 32(8):857-63. PubMed ID: 7201581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic confirmation of myoadenylate deaminase deficiency].
    Navarro-Abia V; Aparicio-Meix JM
    Rev Neurol; 2014 Oct; 59(8):382-3. PubMed ID: 25297483
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myopathy in AMP deaminase deficiency].
    Pongratz DE
    Verh Dtsch Ges Inn Med; 1986; 92():508-12. PubMed ID: 3811553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.